Pfizer

Trending Medical and health breaking news Pfizer seeks conditional EU authorization for COVID-19 pill

Trending Medical and well being breaking information Pfizer seeks conditional EU authorization for COVID-19 tablet

Credit: Pixabay/CC0 Public Domain The European drug regulator said Monday it has started evaluating an application by Pfizer for its pill to treat the effects of COVID-19. The announcement comes as countries in much of the 27-nation bloc are reporting soaring numbers of infections as the highly transmissible omicron variant sweeps across the continent. The…

Trending Medical and health breaking news FDA Backs Pfizer Booster for 12-Year-Olds

Trending Medical and well being breaking information FDA Backs Pfizer Booster for 12-12 months-Olds

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The FDA on Monday authorized the first COVID-19 vaccine booster dose for American adolescents ages 12 to 15. Besides updating the authorization for the Pfizer COVID-19 vaccine, the agency also shortened the recommended time between a second dose and the booster…

Trending Medical and health breaking news FDA may allow Pfizer boosters for 12-year-olds by Monday

Trending Medical and well being breaking information FDA could permit Pfizer boosters for 12-year-olds by Monday

Younger adolescents may soon be eligible for COVID-19 booster vaccines, possibly by early next week. The U.S. Food and Drug Administration is planning on Monday to broaden booster eligibility to include 12- to 15-year-olds, sources told The New York Times. This would be for the Pfizer-BioNTech shot, currently the only COVID-19 vaccine approved for this…

Trending Medical and health breaking news FDA Authorizes Pfizer Antiviral Pill for COVID-19

Trending Medical and well being breaking information FDA Authorizes Pfizer Antiviral Capsule for COVID-19

Dec. 22, 2021 — The FDA on Wednesday granted emergency use authorization for a new antiviral pill to treat people with symptomatic COVID-19.Pfizer’s ritonavir, name brand Paxlovid, can now be taken by patients ages 12 and up who weigh at least 88 pounds.The antiviral is only for people who test positive for the coronavirus, and…

Trending Medical and health breaking news Pfizer: Final Data Shows COVID Pill Stays Strong Against Severe Illness

Trending Medical and well being breaking information Pfizer: Last Information Reveals COVID Tablet Stays Robust Towards Extreme Sickness

By Robin Foster HealthDay Reporter TUESDAY, Dec. 14, 2021 (HealthDay News) — Pfizer Inc. announced Tuesday that a final analysis shows its experimental antiviral pill Paxlovid sharply reduced hospitalizations and deaths among people at high risk for severe illness.The latest results, which reinforce an earlier analysis released in November, Pfizer’s drug cut hospitalizations and deaths…

Trending Medical and health breaking news Pfizer COVID Vaccine for Younger Children Hits Snag

Trending Medical and health breaking news Pfizer COVID Vaccine for Younger Children Hits Snag

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Dec. 17, 2021 — Pfizer’s COVID-19 vaccine for children ages 2 to 5 years old fizzled in clinical trials, the company said on Friday, signaling a further delay in getting a vaccine to preschoolers just as Omicron bears down on the U.S. In…

Trending Medical and health breaking news FDA, CDC Authorize Pfizer Boosters for 16-year-olds

Trending Medical and well being breaking information FDA, CDC Authorize Pfizer Boosters for 16-year-olds

Dec. 9, 2021 — The FDA has authorized booster doses of Pfizer’s COVID-19 vaccine, clearing the way for millions of teenagers to get a third dose of vaccine starting 6 months after their second dose. The CDC quickly followed suit, allowing the boosters to begin immediately. The FDA said it was basing its emergency use authorization…

Trending Medical and health breaking news Pfizer Says Vaccine Booster Should Protect Against Omicron

Trending Medical and well being breaking information Pfizer Says Vaccine Booster Ought to Defend Towards Omicron

Dec. 8, 2021 — A raft of new studies, released overnight that looked at the ability of Omicron to evade currently available vaccines, suggest a substantial loss of protection against the highly mutated variant.The new studies, from teams of researchers in Germany, South Africa, Sweden, and the drug company Pfizer, showed 25- to 40-fold drops…

Trending Medical and health breaking news Pfizer or Moderna: Which COVID Vaccine Is Better?

Trending Medical as well as health and wellness splitting information Pfizer or Moderna: Which COVID Vaccination Is Much Better?

By Robert Preidt HealthDay Reporter THURSDAY, Dec. 2, 2021 (HealthDay News) — Which coronavirus vaccine is best at beating COVID-19 — Moderna or Pfizer? New research hands that honor to Moderna: In what is billed as the first head-to-head comparison of the two shots, researchers analyzed the health records of nearly 440,000 U.S. veterans who…

Trending Medical and health breaking news Pfizer Plans to Seek Booster Approval for 16-Year-Olds

Trending Medical as well as health and wellness splitting information Pfizer Program to Look For Booster Authorization for 16-Year-Olds

Nov. 30, 2021 — Pfizer and BioNTech plan to apply for FDA authorization this week for a booster COVID-19 vaccine for 16- and 17-year-olds.“We expect to share updates on this soon,” Kit Longley, a Pfizer spokesman, told The Washington Post.The FDA could authorize the extra dose within a week. If approved, the additional shot would…